Form 4 for IART INTEGRA LIFESCIENCES HOLDINGS CORP
Accepted 2023-06-02 00:00:00 ET · period of report 2023-06-01 · accession 0001209191-23-033676 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-02 | 2023-06-01 | IART | De Witte Jan | Pres, CEO, Dir | P - Purchase | $38.50 | +7,792 | 12.8K | +156% | +$300.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-01 | P | A | 7,792 | $38.50 | 12,798 | D | — | — | (F1) The price shown above represents the weighted average price of the shares purchased. The range of the purchase prices was $38.46 to $38.50. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. |